Experimental Medicine Might Rescue People With Drug-Resistant HIV

FRIDAY, Oct. 28, 2016 — Researchers report that a new medication might revolutionize the treatment of HIV patients who don’t respond to existing drugs.
The intravenous drug, known as ibalizumab, is given every two weeks. It’s now in the final stage…
Source: Topamax